Weight Losing Drugs Orlistat Powder CAS 96829-58-2

Min.Order: 50

Product origin: Wuhan, Hubei, China

Infringement complaint:

Complaint

US$ 50

Description

Weight Losing Drugs Orlistat Powder CAS 96829-58-2

Product name:Orlistat Powder
CAS Numbers:96829-58-2
Appearance:White needle crystal or powder
Quality standard:GMP
Packing specification:1kg/bag
Melting point:45
Purity:98.0%
Appearance:White powder
Usage:Used for curing obesity

Product name	Lead(II) acetate Trihydrate	Manufacture Date	May,16,2020
Lot Number	GL180420	Analysis Date	May,18,2020
CAS Number	6080-56-4	Lot quantity	500kg
Molecular Formula	CH3COO)2Pb·3H2O	Brand	KMBK
ITEM	STANDARD	RESULTS
ASSAY%≥	99	99.5
APPEARANCE	WHITE CRYSTAL POWDER	WHITE CRYSTAL POWDER
CLEAR DEGREE TEST	CONFORM	CONFORM
WATER INSOLUBLE% ≤	0.005	0.002
CL% ≤	≤0.005	0.002
F% ≤	≤0.001	0.000064
Na≤	≤0.005	0.00085
K%≤	≤0.005	0.000027
N%≤	≤0.001	0.0008
Ca%≤	≤0.005	0.00015
CU% ≤	≤0.001	0.000031

Description

Orlistat is a non-systemic effects of anti-obesity drugs for specific gastrointestinal lipase inhibitor, combined with dietary restrictions can help promote weight loss and prevent weight regain. Gastrointestinal lipases break down fats in the gastrointestinal tract is necessary enzymes, orlistat inhibits stomach, pancreatic and hydroxy acid esterase, primarily through the stomach, small intestine lumen of the stomach and pancreatic lipases active serine parts form a covalent bond, to inactivate enzymes play a therapeutic role.

Applicaiton:
Orlistat is used for the treatment of obesity. The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body mass.After orlistat was stopped, a significant number of subjects regained weight-up to 35% of the weight they had lost. The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%).Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively).

NMN CAS: 1094-61-7
Nr CAS: 1341-23-7
Procaine CAS :59-46-1
Benzocaine CAS :94-09-7
Lidocaine CAS:137-58-6
Acetaminophen CAS :103-90-2
Boric acid CAS : 11113-50-1
Tetracain hcl CAS :136-47-0
Valerophenoone CAS :1009-14-9
Tetramisole hcl CAS:5086-74-8
Procaine hcl CAS:51-05-8
Benzocaine CAS:94-09-7
CAS:137-58-6
Ethephon CAS:16672-87-0
New BMK CAS:5413-05-8
(2-Bromoethyl)benzene CAS:103-63-9
Clotrimazole CAS:23593-75-1
Tretinoin CAS:302-79-4 ETC.
4'-Methylpropiophenone CAS 5337-93-9
Benzene CAS 103-63-9

By Express	By Air	By Sea
Suitable for under 50kg	Suitable for more than 50kg	Suitable for more than 500kg
Fast: 3-7 days	Fast: 3-7 days	slow: 3-7 days
High cost	Medium cost	Low cost
Door to door service	Port to port service	Port to port service